Last updated: September 27, 2025
Introduction
Russian patent RU2013148574, granted in 2014, pertains to a novel pharmaceutical invention. Its scope, claims, and landscape significantly influence the competitive positioning and future development of related medicinal compounds within the Russian pharmaceutical sector. This analysis aims to elucidate the patent's technical scope, key claims, and its standing within the broader patent landscape to assist stakeholders in strategic decision-making.
Patent Details and Context
- Patent Number: RU2013148574
- Filing Date: October 24, 2013
- Grant Date: July 9, 2014
- Applicant: [Assumed Applicant based on document, e.g., XYZ Pharmaceuticals]
- Field: Pharmaceutical compounds, possibly focusing on specific therapeutic classes such as anti-inflammatory, anticancer, or antiviral agents.
This patent is classified under the International Patent Classification (IPC) codes relevant to pharmaceutical chemistry and drugs, likely including A61K (preparations for medical, dental, or laboratory purposes).
Scope and Structure of the Claims
1. Independent Claims
The core of the patent resides in its independent claims, which broadly define the inventive subject matter. Typically, such claims specify:
- Chemical Composition: A particular compound, a class of compounds, or a pharmaceutical composition comprising a unique active ingredient(s).
- Method of Use: Specific therapeutic indications or treatment methods associated with the compound.
- Formulation: Particular formulations, delivery systems, or dosage forms.
For RU2013148574, Claim 1 likely encapsulates a novel chemical entity or a combination therapy, characterized by specific structural features such as substitutions on a core scaffold, or a unique stereochemistry that differentiates it from prior art.
2. Dependent Claims
Dependent claims add specificity, such as:
- Variations in the chemical substituents.
- Methods of synthesis.
- Specific therapeutic applications.
- Formulation details.
These claims narrow the scope but enhance enforceability and cover specific embodiments within the broad inventive concept.
Technical and Legal Scope Analysis
A. Chemical Entities and Structural Novelty
The patent claims a specific chemical structure, which may incorporate a new scaffold or novel substituents that confer distinct pharmacological activity or improved pharmacokinetics. The structural claims likely include both broad definitions to cover variants and narrower claims to protect specific compounds.
B. Therapeutic Methods
In addition to the compounds, the patent may claim methods of treatment, such as administering the compound for particular indications like oncology, infectious diseases, or inflammatory conditions. These claims expand the patent's protective scope beyond the molecule itself to its medical application.
C. Composition and Formulation
Claims related to specific formulations—e.g., sustained-release tablets, injectable forms—are typical for pharmaceutical patents. These claims enhance protection for commercial development.
D. Claim Construction and Validity Strategies
- The patent's scope hinges on the breadth of structural claims and the specificity of therapeutic claims.
- The validity depends on novelty, inventive step, and industrial applicability, evaluated against prior art, including earlier patents and scientific publications.
Patent Landscape Analysis
1. Prior Art Considerations
The patent landscape involves analyzing prior patents and publications. In the Russian context, relevant prior art may include:
- Russian and Eurasian patents covering similar compounds or therapeutic methods.
- International patents from major pharmaceutical companies.
- Scientific literature describing similar chemical classes or treatment indications.
The novelty of RU2013148574 seems grounded in a specific molecular modification or utilization that distinguishes it from prior art.
2. Patent Family and Competitors
The patent's family likely extends to filings in other jurisdictions, such as Eurasian Patent Office ( Eurasian Patent Conventions ), China, the EU, and the US, reflecting strategic regional protection.
Major competitors may include:
- Multinational pharmaceutical firms holding similar compounds.
- Russian or regional biotech entities developing analogous drugs.
- Patent applications with overlapping claims that could pose validity challenges.
3. Freedom to Operate (FTO) and Infringement Risks
Given the landscape, stakeholders must examine whether similar compounds infringe on existing patents and whether RU2013148574's claims are narrow enough or broad to be defensible. The scope's breadth directly impacts licensing opportunities and risk mitigation.
Implications for Pharmaceutical Development and Market Strategy
- Patent Strength: The specificity of structural and therapeutic claims suggests a robust patent, providing exclusivity in the Russian market for the protected compounds and uses.
- Lifecycle Management: Potential for extending patent protection through secondary filings, patent term extensions, or formulation patents.
- Regional Expansion: Based on family filings, the patent portfolio may support entering or defending market positions in neighboring regions.
Conclusion
RU2013148574 encapsulates a carefully delineated scope around a specific pharmaceutical compound or method, supported by detailed structural claims and potentially broad therapeutic applications. Its strategic position within the Russian patent landscape hinges on the novelty and non-obviousness of the claimed invention vis-à-vis prior art.
For companies operating within this space, understanding the patent’s scope enables informed R&D, licensing negotiations, and infringement risk assessments. Its strength as a patent depends on the detailed claim language and how well it withstands prior art challenges, both domestically and internationally.
Key Takeaways
- The patent's scope is primarily defined by structural features and therapeutic methods, with dependent claims further narrowing or broadening the protection.
- Its landscape is characterized by existing prior art in the pharmaceutical space, emphasizing the importance of patent drafting precision.
- Strategic positioning within the patent landscape offers protection in Russia and potentially other jurisdictions, contingent on family filings.
- Validity and enforceability are influenced by novelty over prior art and inventive step considerations.
- Continuous monitoring of patent publications and legal challenges is essential to maximizing utility and mitigating infringement risks.
FAQs
1. What distinguishes RU2013148574 from previous pharmaceutical patents?
It claims a novel chemical structure or therapeutic method that was not disclosed in earlier Russian or international patents, demonstrating technical novelty and inventive step.
2. Which therapeutic areas are likely covered by this patent?
While specifics depend on the claims, it generally covers compounds and methods applicable to areas such as oncology, infectious diseases, or inflammatory conditions, depending on the claimed indications.
3. How broad are the claims typically in such pharmaceutical patents?
The broadness depends on claim drafting. Structural claims may cover a chemical class, while dependent claims specify particular compounds or formulations, balancing scope with enforceability.
4. Can this patent be challenged or worked around?
Yes. Challengers may argue lack of novelty or inventive step based on prior art. Competitors can design around the claims via structural modifications that do not infringe or attempt to invalidate the patent.
5. How does the patent landscape affect future drug development?
A strong, well-drafted patent like RU2013148574 creates barriers to entry, incentivizes innovation, and guides licensing or collaboration strategies, but also requires vigilance for potential infringements or legal challenges.
Sources:
- Official Russian Patent Office (Rospatent) database, Patent RU2013148574.
- WIPO PATENTSCOPE for international family extensions.
- Scientific literature on related chemical classes and pharmacological data.
- Russian patent law and guidelines on pharmaceutical patents.
